Trial Profile
Open Study on the Efficacy and Safety of Combivent(R) Aerosol (120 mcg Salbutamol Sulfate Plus 20 mcg Ipratropium Bromide) + Spacer, 12 to 24 Puffs, in Adult Patients With Moderate to Severe Asthma Crisis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2014
Price :
$35
*
At a glance
- Drugs Ipratropium-bromide/salbutamol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 24 Jul 2014 New trial record